To Buy Under 5 — Stocks

Consensus rating of "Buy" with an average price target of $5.87 .

Analysts maintain a "Strong Buy" consensus with a median price target of $7.20 , suggesting a massive 309% upside .

Many companies at this price point are currently unprofitable and rely on fresh capital to fund operations. stocks to buy under 5

AI responses may include mistakes. For financial advice, consult a professional. Learn more

Analysts have upgraded KULR to a "Strong Buy" with a 1-year target of $5.00 . Consensus rating of "Buy" with an average price target of $5

April 2026 Penny Stocks With Growth Potential - Yahoo Finance

Their lead drug candidate, micvotabart pelidotin (MICVO) , has received FDA Fast Track Designation for head and neck cancer. Preliminary Phase 1 clinical data is expected to be a major "make-or-break" milestone in late 2025 and through 2026. Zentalis Pharmaceuticals (ZNTL) Sector: Healthcare (Biotechnology) Current Price: Approximately $3.74 AI responses may include mistakes

Zentalis is developing azenosertib, a first-in-class cancer treatment. The company expects to release topline data from its DENALI Part 2 trial by the end of 2026, which could lead to accelerated FDA approval. KULR Technology Group (KULR) Sector: Technology (Energy Storage) Current Price: Approximately $1.28